Senior Manager, Payer Evidence, Methods, & Access Affairs

The role is responsible for unlocking the value of AstraZeneca’s medicines in Canada by shaping HTA decision-making frameworks and advancing payer evidence practices. Reporting to the Director, PEMA, the position builds overarching payer evidence plans, cultivates relationships across the HTA ecosystem, and drives strategic initiatives to support positive HTA recommendations and faster patient access. The role also integrates international best practices and provides thought leadership on health economic methods for the Canadian healthcare environment.